SCHEMBL2962849

SCHEMBL2962849

OCc1c(-c2ccccc2)oc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ LMNA P02545 3/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ ALOX15 P16050 2/20 0.53
▸ MAPK1 P28482 2/20 0.53
▸ TP53 P04637 2/20 0.53
▸ CA12 O43570 1/20 0.53
▸ CA1 P00915 1/20 0.53
▸ CA2 P00918 1/20 0.53
▸ ABCB1 P08183 1/20 0.53
▸ CALM1 P0DP23 1/20 0.53
▸ AR P10275 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ CYP1B1 Q16678 1/20 0.53
▸ CA9 Q16790 1/20 0.53
▸ DDR2 Q16832 1/20 0.49
▸ ADORA3 P0DMS8 1/20 0.49
▸ GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049706 0.88 PTPN1 (0.45) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL19846946 0.86 KMT2A (0.64) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049701 0.86 LMNA (0.57) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13080176 0.86 CYP3A4 (0.42) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049721 0.86 MAPK14 (0.49) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049691 0.84 MEN1 (0.43) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049690 0.82 MEN1 (0.60) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049711 0.82 KDM4E (0.49) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049693 0.82 MAPT (0.48) KMT2AKDM4EMEN1LMNACYP3A4
SCHEMBL13049759 0.82 CYP19A1 (0.52) KMT2AKDM4EMEN1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7772237-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2010-08-10 — — US disclosed
US-7772237-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2010-08-10 — — US disclosed
US-7772237-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2010-08-10 — — US disclosed
US-20090105241-A1 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES CEPHALON FRANCE (FR) 2009-04-23 — — US disclosed
US-20090105241-A1 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES CEPHALON FRANCE (FR) 2009-04-23 — — US disclosed
US-20090105241-A1 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES CEPHALON FRANCE (FR) 2009-04-23 — — US disclosed
US-7476690-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2009-01-13 — — US disclosed
US-7476690-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2009-01-13 — — US disclosed
US-7476690-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2009-01-13 — — US disclosed
EP-1735300-A1 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES CEPHALON FRANCE (FR) 2006-12-27 — — EP disclosed
US-20060241119-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2006-10-26 — — US disclosed
US-7119214-B2 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2006-10-10 — — US disclosed
US-20050282821-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2005-12-22 — — US disclosed
WO-2005100345-A1 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES CEPHALON FRANCE (FR) 2005-10-27 — — WO disclosed
EP-1589016-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives CEPHALON FRANCE (FR) 2005-10-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282821-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives HTR1A, HTR2A, HTR5A KMT2A 1455/4885KDM4E 1472/4885MEN1 3887/4885
US-20060241119-A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives HTR1A, HTR2A, HTR5A KMT2A 1455/4885KDM4E 1472/4885MEN1 3887/4885
US-20090105241-A1 THIO-SUBSTITUTED TRICYCLIC AND BICYCLIC AROMATIC METHANESULFINYL DERIVATIVES HTR1A, HTR2A, HTR5A KMT2A 1455/4885KDM4E 1472/4885MEN1 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback